Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Ellis G Levine"'
Autor:
Lauren Williams, Paul K Wallace, Pawel Kalinski, Mateusz Opyrchal, Kathleen M Kokolus, Shipra Gandhi, Kristopher Attwood, Agnieszka Witkiewicz, Hans Minderman, Kah Teong Soh, Melissa J Grimm, Ronald T Slomba, Adrienne Groman, Mary Lynne Tarquini, Orla Maguire, Tracey L O’Connor, Amy P Early, Ellis G Levine
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Presence of cytotoxic T lymphocytes (CTL) in the tumor microenvironment (TME) predicts the effectiveness of cancer immunotherapies. The ability of toll-like receptor 3 (TLR3) ligands, interferons (IFNs) and COX2 inhibitors to synergistical
Externí odkaz:
https://doaj.org/article/2d1ecf8be6c34222ae25dc9f47cf3dc6
Autor:
Ajay Dhakal, Roby Antony Thomas, Ellis G Levine, Adam Brufsky, Kazuaki Takabe, Matthew G Hanna, Kristopher Attwood, Austin Miller, Thaer Khoury, Amy P Early, Saif Soniwala, Tracy O’Connor, Mateusz Opyrchal
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
Background: Despite the approval of mTOR inhibitor everolimus and CDK4/6 inhibitors in the management of hormone-receptor-positive HER2 non-amplified metastatic breast cancer (HR+ HER2-MBC), the optimal sequence of therapy is unclear. There are no cl
Externí odkaz:
https://doaj.org/article/ab6219d74f2a4b79adec209c9ce08069
Autor:
Foluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B Edge, Adam R Karpf, Smith A James, Christine B Ambrosone, Tracey L O'Connor, Ellis G Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38783 (2012)
NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (
Externí odkaz:
https://doaj.org/article/ef744e6ac0f54ea59e960777fb415c60
Autor:
Adith Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Sarah Asad, Daniel G. Stover
Publikováno v:
The Breast. 67:89-93
Autor:
Adith S. Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce Niland, Antonio C. Wolff, Michael J. Hassett, Daniel G. Stover, Sarah Asad
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-033
Autor:
Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor, Tracey O’Connor, Amy Early, Ellis G. Levine, Kazuaki Takabe, Pawel Kalinski, Christine Ambrosone, Thaer Khoury, Song Yao, Shipra Gandhi
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To examine the association between race and clinical outcomes (pathological complete response [pCR]; recurrence free survival [RFS], and overall survival [OS]) in patients diagnosed with triple-negative (TNBC) or HER2-positive breast cancer
Autor:
Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O’Connor, Amy Early, Ellis G. Levine, Shipra Gandhi
Publikováno v:
Frontiers in Oncology. 12
BackgroundIt is critically important to study the real-world data of FDA-approved medications to understand the response rates and toxicities observed in the real-world population not represented in the clinical trials.MethodsWe reviewed charts of pa
Autor:
Jennifer K Lang, Ellis G. Levine, Amy P. Early, Rachael Hageman Blair, Adolfo Quiñones-Lombraña, Badri Karthikeyan, Tracey O'Connor, Umesh C. Sharma, Javier G. Blanco
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-10 (2021)
Cardio-oncology
Cardio-oncology
Background The CBR3 V244M single nucleotide polymorphism has been linked to the risk of anthracycline-related cardiomyopathy in survivors of childhood cancer. There have been limited prospective studies examining the impact of CBR3 V244M on the risk
Autor:
Lisa Blumencranz, Raye Budway, Michaela Tsai, Robin Zon, Joseph McKelley, Rubina Qamar, Hatem Soliman, Sarah Untch, B Mavromatis, Shelly S. Lo, Pat Whitworth, William Audeh, Ellis G. Levine
Publikováno v:
Cancer Research. 80:P2-14
Background: The PROMIS trial (NCT01617954) previously evaluated how a definitive result from the MammaPrint 70-gene signature (70-GS) can impact treatment recommendations for patients with an intermediate range recurrence score (RS 18-30) from the 21
Autor:
William Audeh, Varsha Shah, Rubina Qamar, Ellis G. Levine, Gordan Srkalovic, Reshma Mahtani, Sarah Untch, Heather M. Kling, Robert Gabordi, B Mavromatis, Tina Treece, Hatem Soliman, Mohamad Kassar, Jayanthi Srinivasiah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer
BMC Cancer
Background Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence based on